Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Transcriptional Repression of the LMO2 Oncogene By Ikaros in T-Cell Acute Lymphoblastic Leukemia

Yali Ding, PhD, Chunhua Song, PhD, Chandrika S. Gowda, MD, Malika Kapadia, Kimberly Payne, PhD, Sinisa Dovat, MDPhD

Blood (2016) 128 (22): 439.

https://doi.org/10.1182/blood.V128.22.439.439

Published: 2016

Journal Articles

Clinical Significance of High C -MYC and Low MYCBP2 Expression and Their Association with Ikaros Dysfunction in Adult Acute Lymphoblastic Leukemia

Zheng Ge, MD PhD, Xing Guo, MD, Jianyong Li, MD PhD, Melanie Hartman, Yuka Imamura Kawasawa, Sinisa Dovat, MDPhD, Chunhua Song, PhD

Blood (2015) 126 (23): 3713.

https://doi.org/10.1182/blood.V126.23.3713.3713

Published: 2015

Journal Articles

Targeting Casein Kinase II Exerts a Therapeutic Effect in Pediatric High Risk Leukemia Via Inhibition of Cell Cycle Progression and the PI3K Pathway

Chandrika S. Gowda, MD, Chunhua Song, PhD, Yali Ding, PhD, Sunil Muthusami, MD, Kimberly Payne, PhD, Zheng Ge, Sinisa Dovat, MDPhD

Blood (2015) 126 (23): 4800.

https://doi.org/10.1182/blood.V126.23.4800.4800

Published: 2015

Journal Articles

Clinical Significance of WDR5 High Expression and Its Effect on Tumorigenesis in Adult Leukemia

Zheng Ge, MD PhD, Evelyn Song, BS, Jianyong Li, MD PhD, Sinisa Dovat, MDPhD, Chunhua Song, PhD

Blood (2015) 126 (23): 3657.

https://doi.org/10.1182/blood.V126.23.3657.3657

Published: 2015

Journal Articles

Restoring Ikaros Function in Leukemia : Casein Kinase II ( CK2) Inhibition Restores Ikaros Tumor Supressor Function and Shows Theraputic Efficacy in Preclinical Models of High Risk Pediatric Leukemia

Chandrika S. Gowda, MD, Chunhua Song, MD, PhD, Sunil Muthusami, MD, Yali Ding, PhD, Mansi Sachdev, MD, Kimberly Payne, PhD, Sinisa Dovat, MDPhD

Blood (2014) 124 (21): 3712.

https://doi.org/10.1182/blood.V124.21.3712.3712

Published: 2014

NARROW

Transcriptional Repression of the LMO2 Oncogene By Ikaros in T-Cell Acute Lymphoblastic Leukemia

Clinical Significance of High C -MYC and Low MYCBP2 Expression and Their Association with Ikaros Dysfunction in Adult Acute Lymphoblastic Leukemia

Targeting Casein Kinase II Exerts a Therapeutic Effect in Pediatric High Risk Leukemia Via Inhibition of Cell Cycle Progression and the PI3K Pathway

Clinical Significance of WDR5 High Expression and Its Effect on Tumorigenesis in Adult Leukemia

Restoring Ikaros Function in Leukemia : Casein Kinase II ( CK2) Inhibition Restores Ikaros Tumor Supressor Function and Shows Theraputic Efficacy in Preclinical Models of High Risk Pediatric Leukemia

Email alerts

ASH Publications

American Society of Hematology

Transcriptional Repression of the LMO2 Oncogene By Ikaros in T-Cell Acute Lymphoblastic Leukemia

Clinical Significance of High C -MYC and Low MYCBP2 Expression and Their Association with Ikaros Dysfunction in Adult Acute Lymphoblastic Leukemia

Targeting Casein Kinase II Exerts a Therapeutic Effect in Pediatric High Risk Leukemia Via Inhibition of Cell Cycle Progression and the PI3K Pathway

Clinical Significance of WDR5 High Expression and Its Effect on Tumorigenesis in Adult Leukemia

Restoring Ikaros Function in Leukemia : Casein Kinase II ( CK2) Inhibition Restores Ikaros Tumor Supressor Function and Shows Theraputic Efficacy in Preclinical Models of High Risk Pediatric Leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only